LSU AI platform used to create COVID-19 treatment

LSU researchers and drug company Skymount Medical are beginning studies on COVID-19 patients involving a combination of medicines, known as SM-19, that have shown to reduce viral load in initial tests…

Already an INSIDER? Sign in.

We are glad you enjoy reading Business Report.

Continue reading this story and get ACCESS to all our content from any device with a subscription now.

  • Get access to more than a decade of story archives.
  • Get access to our searchable data center of TOP LISTS.
  • Get exclusive content only available to INSIDERS.